Exelixis
EXEL
#1760
Rank
ยฃ8.46 B
Marketcap
ยฃ31.46
Share price
-0.71%
Change (1 day)
14.05%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company